Birmingham Capital Management’s Boston Scientific BSX Stock Holding History

Birmingham Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,000	Closed	-$215K	–	93
2025 Q2	$215K	Hold	2,000	–	–	0.1%	97
2025 Q1	$202K	Buy	+2,000	New	+$201K	0.08%	107
2020 Q1	–	Sell	-7,000	Closed	-$317K	–	92
2019 Q4	$317K	Hold	7,000	–	–	0.14%	84
2019 Q3	$285K	Hold	7,000	–	–	0.13%	87
2019 Q2	$301K	Hold	7,000	–	–	0.14%	84
2019 Q1	$269K	Hold	7,000	–	–	0.12%	85
2018 Q4	$247K	Hold	7,000	–	–	0.12%	86
2018 Q3	$270K	Hold	7,000	–	–	0.11%	87
2018 Q2	$229K	Buy	+7,000	New	+$211K	0.1%	94
2017 Q4	–	Sell	-7,000	Closed	-$204K	–	101
2017 Q3	$204K	Buy	+7,000	New	+$193K	0.08%	102
2013 Q4	–	Sell	-15,000	Closed	-$176K	–	107
2013 Q3	$176K	Hold	15,000	–	–	0.07%	104
2013 Q2	$139K	Buy	+15,000	New	+$127K	0.06%	103

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Birmingham Capital Management's BSX Position: Q3 2025 in Review

Birmingham Capital Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,000 shares — an estimated $215K sold.

Birmingham Capital Management first reported a position in BSX in Q2 2013 and held it in 12 quarters. The position peaked at $317K in Q4 2019. 1,712 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

Birmingham Capital Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
Birmingham Capital Management sold 2,000 Boston Scientific shares in Q3 2025, an estimated $215K.
Birmingham Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 12 quarters.
Birmingham Capital Management's Boston Scientific position peaked at $317K in Q4 2019.
1,712 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Birmingham Capital Management's 13F filing for Q3 2025, filed 5 Nov 2025.